Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Research & Development (2020 - 2025)

Historic Research & Development for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $551104.0.

  • iSpecimen's Research & Development fell 2698.0% to $551104.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 2712.58%. This contributed to the annual value of $3.5 million for FY2024, which is 102.68% down from last year.
  • Per iSpecimen's latest filing, its Research & Development stood at $551104.0 for Q3 2025, which was down 2698.0% from $536311.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Research & Development ranged from a high of $967831.0 in Q4 2023 and a low of $361799.0 during Q2 2021
  • In the last 5 years, iSpecimen's Research & Development had a median value of $740410.0 in 2022 and averaged $696008.3.
  • In the last 5 years, iSpecimen's Research & Development surged by 7569.15% in 2022 and then tumbled by 4118.93% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Research & Development stood at $522551.0 in 2021, then surged by 41.69% to $740410.0 in 2022, then skyrocketed by 30.72% to $967831.0 in 2023, then fell by 1.67% to $951667.0 in 2024, then plummeted by 42.09% to $551104.0 in 2025.
  • Its Research & Development was $551104.0 in Q3 2025, compared to $536311.0 in Q2 2025 and $545367.0 in Q1 2025.